BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18574254)

  • 1. Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL).
    Talaulikar D; Dahlstrom JE; Shadbolt B; Broomfield A; McDonald A
    J Histochem Cytochem; 2008 Oct; 56(10):893-900. PubMed ID: 18574254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).
    Talaulikar D; Shadbolt B; Dahlstrom JE; McDonald A
    J Hematol Oncol; 2009 Nov; 2():49. PubMed ID: 19930611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
    Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
    Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
    Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
    Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
    Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations.
    Talaulikar D; Dahlstrom JE
    Pathology; 2009; 41(3):214-22. PubMed ID: 19291532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
    J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
    Baiyee D; Warnke R; Natkunam Y
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):93-5. PubMed ID: 19521275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of germinal center B-cell-like and non-germinal center B-cell-like subtypes of bone marrow involvement in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Cho MC; Chung Y; Jang S; Park CJ; Chi HS; Huh J; Suh C; Shim H
    Medicine (Baltimore); 2018 Nov; 97(45):e13046. PubMed ID: 30407302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
    Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
    Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas.
    Kim JS; Gang GW; Lee SR; Sung HJ; Park Y; Kim DS; Choi CW; Kim BS
    Jpn J Clin Oncol; 2015 Oct; 45(10):914-20. PubMed ID: 26185139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study.
    Alzahrani M; El-Galaly TC; Hutchings M; Hansen JW; Loft A; Johnsen HE; Iyer V; Wilson D; Sehn LH; Savage KJ; Connors JM; Gascoyne RD; Johansen P; Clasen-Linde E; Brown P; Villa D
    Ann Oncol; 2016 Jun; 27(6):1095-1099. PubMed ID: 27002106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision of histological bone marrow staging in follicular lymphoma and diffuse large B-cell lymphoma.
    Chen T; McDonald A; Shadbolt B; Talaulikar D
    Clin Invest Med; 2012 Dec; 35(6):E358-64. PubMed ID: 23217561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma.
    Cho YA; Yang WI; Song JW; Min YH; Yoon SO
    Cancer Med; 2016 Jun; 5(6):1066-73. PubMed ID: 26923640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of bone marrow fibrosis in diffuse large B-cell lymphoma.
    Cetintepe T; Ozkan G; Kucukzeybek BP; Cetintepe L; Unal DK; Solmaz S; Aygun K; Acar AG; Bener S; Çallı AO; Payzın KB
    Int J Lab Hematol; 2024 Jun; 46(3):523-530. PubMed ID: 38361314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.
    Song MK; Yang DH; Lee GW; Lim SN; Shin S; Pak KJ; Kwon SY; Shim HK; Choi BH; Kim IS; Shin DH; Kim SG; Oh SY
    Leuk Res; 2016 Mar; 42():1-6. PubMed ID: 26851438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.